765 related articles for article (PubMed ID: 15517904)
21. Combination of the antivascular agent ZD6126 with hypoxic cytotoxin treatment, with reference to the effect on quiescent tumor cells and the dependency on p53 status of tumor cells.
Masunaga S; Nagasawa H; Uto Y; Hori H; Ohnishi K; Takahashi A; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Ono K
Oncol Rep; 2005 Aug; 14(2):393-400. PubMed ID: 16012721
[TBL] [Abstract][Full Text] [Related]
22. Radiobiologic significance of response of intratumor quiescent cells in vivo to accelerated carbon ion beams compared with gamma-rays and reactor neutron beams.
Masunaga S; Ando K; Uzawa A; Hirayama R; Furusawa Y; Koike S; Sakurai Y; Nagata K; Suzuki M; Kashino G; Kinashi Y; Tanaka H; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):221-8. PubMed ID: 18086390
[TBL] [Abstract][Full Text] [Related]
23. Intra-arterial administration of sodium borocaptate (BSH)/lipiodol emulsion delivers B-10 to liver tumors highly selectively for boron neutron capture therapy: experimental studies in the rat liver model.
Suzuki M; Masunaga S; Kinashi Y; Nagata K; Sakurai Y; Nakamatsu K; Nishimura Y; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):260-6. PubMed ID: 15093923
[TBL] [Abstract][Full Text] [Related]
24. Repair of potentially lethal damage by total and quiescent cells in solid tumors following a neutron capture reaction.
Masunaga S; Ono K; Suzuki M; Sakurai Y; Takagaki M; Kobayashi T; Kinashi Y; Akaboshi M
J Cancer Res Clin Oncol; 1999 Nov; 125(11):609-14. PubMed ID: 10541967
[TBL] [Abstract][Full Text] [Related]
25. Effect of electroporation on cell killing by boron neutron capture therapy using borocaptate sodium (10B-BSH).
Ono K; Kinashi Y; Masunaga S; Suzuki M; Takagaki M
Jpn J Cancer Res; 1998 Dec; 89(12):1352-7. PubMed ID: 10081497
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells.
Masunaga SI; Ono K; Kirihata M; Takagaki M; Sakurai Y; Kinashi Y; Kobayashi T; Nagasawa H; Uto Y; Hori H
Jpn J Cancer Res; 2001 Sep; 92(9):996-1007. PubMed ID: 11572769
[TBL] [Abstract][Full Text] [Related]
27. Determination and drug modification assessed by micronucleus frequency assay of potentially lethal damage repair in quiescent cell populations within murine solid tumors.
Masunaga S; Ono K; Akaboshi M; Takagaki M; Kinashi Y; Suzuki M; Abe M
Radiat Med; 1997; 15(1):37-43. PubMed ID: 9134583
[TBL] [Abstract][Full Text] [Related]
28. Effects of p53 status and wortmannin treatment on potentially lethal damage repair, with emphasis on the response of intratumor quiescent cells.
Masunaga S; Takahashi A; Ohnishi K; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Ono K
Radiat Med; 2003; 21(3):120-7. PubMed ID: 12868860
[TBL] [Abstract][Full Text] [Related]
29. The impact of TP53 status of tumor cells including the type and the concentration of administered 10B delivery agents on compound biological effectiveness in boron neutron capture therapy.
Masunaga SI; Sanada Y; Takata T; Tanaka H; Sakurai Y; Suzuki M; Kirihata M; Ono K
J Radiat Res; 2023 Mar; 64(2):399-411. PubMed ID: 36763853
[TBL] [Abstract][Full Text] [Related]
30. Applicability of combination with tirapazamine in boron neutron capture therapy.
Masunaga S; Ono K; Sakurai Y; Hori H; Kobayashi T; Takagaki M; Suzuki M; Kinashi Y; Akaboshi M
Jpn J Cancer Res; 1998 Jul; 89(7):768-74. PubMed ID: 9738984
[TBL] [Abstract][Full Text] [Related]
31. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model.
Kamida A; Obayashi S; Kato I; Ono K; Suzuki M; Nagata K; Sakurai Y; Yura Y
Int J Radiat Biol; 2006 Jan; 82(1):21-9. PubMed ID: 16546900
[TBL] [Abstract][Full Text] [Related]
32. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations.
Masunaga S; Nagasawa H; Uto Y; Hori H; Suzuki M; Nagata K; Kinashi Y; Ono K
Int J Hyperthermia; 2005 Jun; 21(4):305-18. PubMed ID: 16019857
[TBL] [Abstract][Full Text] [Related]
33. Dosimetric study of boron neutron capture therapy with borocaptate sodium (BSH)/lipiodol emulsion (BSH/lipiodol-BNCT) for treatment of multiple liver tumors.
Suzuki M; Sakurai Y; Masunaga S; Kinashi Y; Nagata K; Ono K
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):892-6. PubMed ID: 14967447
[TBL] [Abstract][Full Text] [Related]
34. Biodistribution of 10B in a rat liver tumor model following intra-arterial administration of sodium borocaptate (BSH)/degradable starch microspheres (DSM) emulsion.
Suzuki M; Nagata K; Masunaga S; Kinashi Y; Sakurai Y; Maruhashi A; Ono K
Appl Radiat Isot; 2004 Nov; 61(5):933-7. PubMed ID: 15308171
[TBL] [Abstract][Full Text] [Related]
35. Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy.
Morris GM; Smith DR; Patel H; Chandra S; Morrison GH; Hopewell JW; Rezvani M; Micca PL; Coderre JA
Br J Cancer; 2000 Jun; 82(11):1764-71. PubMed ID: 10839288
[TBL] [Abstract][Full Text] [Related]
36. The radiosensitivity of total and quiescent cell populations in solid tumors to 290 MeV/u carbon ion beam irradiation in vivo.
Masunaga S; Ando K; Uzawa A; Hirayama R; Furusawa Y; Koike S; Ono K
Acta Oncol; 2008; 47(6):1087-93. PubMed ID: 18607878
[TBL] [Abstract][Full Text] [Related]
37. Accumulation of 10B in the central degenerative areas of human glioma and colon carcinoma spheroids after sulfhydryl boron hydride administration.
Pettersson OA; Carlsson J; Grusell E
Cancer Res; 1992 Mar; 52(6):1587-91. PubMed ID: 1540968
[TBL] [Abstract][Full Text] [Related]
38. Effects of boron neutron capture therapy using borocaptate sodium in combination with a tumor-selective vasoactive agent in mice.
Ono K; Masunaga S; Kinashi Y; Takagaki M; Akaboshi M; Suzuki M; Baba H
Jpn J Cancer Res; 1998 Mar; 89(3):334-40. PubMed ID: 9600129
[TBL] [Abstract][Full Text] [Related]
39. Electroporation increases the effect of borocaptate (10B-BSH) in neutron capture therapy.
Ono K; Kinashi Y; Masunaga S; Suzuki M; Takagaki M
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):823-6. PubMed ID: 9845104
[TBL] [Abstract][Full Text] [Related]
40. Potentially lethal damage repair by total and quiescent tumor cells following various DNA-damaging treatments.
Masunaga S; Ono K; Hori H; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y
Radiat Med; 1999; 17(4):259-64. PubMed ID: 10510897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
